Orthofix launches new bioactive synthetic graft
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.
Source: beckersspine.com
Stay updated with breaking news from Trip Configurations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.